Antidepressants for smoking cessation (Q24201167)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24402784%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

John R Hughes

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24402784%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Lindsay F Stead

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24402784%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Jamie Hartmann-Boyce

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24402784%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Kate Cahill

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24402784%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

31 May 2020

publication date

8 January 2014

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24402784%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24402784%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

page(s)

CD000031

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24402784%20AND%20SRC:MED&resulttype=core&format=json

Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial

31 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Self-efficacy and motivation to quit during participation in a smoking cessation program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Successful recruitment of minorities into clinical trials: The Kick It at Swope project

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Predictors of smoking cessation among African-Americans enrolled in a randomized controlled trial of bupropion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Does menthol attenuate the effect of bupropion among African American smokers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

The impact of perceived treatment assignment on smoking cessation outcomes among African-American smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Nortriptyline plus nicotine replacement versus placebo plus nicotine replacement for smoking cessation: pragmatic randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers*

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Effects of past history of major depression on smoking characteristics, monoamine oxidase-A and -B activities and withdrawal symptoms in dependent smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

A randomized controlled trial of oral selegiline plus nicotine skin patch compared with placebo plus nicotine skin patch for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

The effects of fluoxetine combined with nicotine inhalers in smoking cessation--a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Regular exercise as a protective factor in relapse following smoking cessation treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Bupropion and cognitive-behavioral treatment for depression in smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Modeling smoking cessation data with alternating states and a cure fraction using frailty models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Impact of bupropion and cognitive-behavioral treatment for depression on positive affect, negative affect, and urges to smoke during cessation treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Combined effects of venlafaxine, nicotine replacement, and brief counseling on smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

The effects of the DRD2 polymorphism on smoking cessation and negative affect: evidence for a pharmacogenetic effect on mood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Catechol-O-methyltransferase (COMT) gene variants predict response to bupropion therapy for tobacco dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: analysis of pooled data from two clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Pharmacogenetic association of the galanin receptor (GALR1) SNP rs2717162 with smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Can the blind see? Participant guess about treatment arm assignment may influence outcome in a clinical trial of bupropion for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Recurrent event analysis of lapse and recovery in a smoking cessation clinical trial using bupropion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Do small lapses predict relapse to smoking behavior under bupropion treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

A randomized trial of sertraline as a cessation aid for smokers with a history of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

A randomized trial of bupropion and/or nicotine gum as maintenance treatment for preventing smoking relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Design, baseline characteristics, and retention of African American light smokers into a randomized trial involving biological data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Bupropion for smoking cessation in African American light smokers: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Factors associated with smoking menthol cigarettes among treatment-seeking African American light smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Predictors of cessation in African American light smokers enrolled in a bupropion clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

CYP2B6 and bupropion's smoking-cessation pharmacology: the role of hydroxybupropion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

The prevalence of weight concerns in a smoking abstinence clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

A multicenter, randomized, double-blind, placebo-controlled, 6-month trial of bupropion hydrochloride sustained-release tablets as an aid to smoking cessation in hospital employees

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Smoking cessation after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

An evaluation of the Italian version of the Fagerström Test for Nicotine Dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Comparing smoking treatment programs for lighter smokers with and without a history of heavier smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

A placebo controlled trial of bupropion for smoking cessation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

A preliminary placebo-controlled trial of selegiline hydrochloride for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: a randomized placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Bupropion and nicotine patch as smoking cessation aids in alcoholics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

A controlled trial of nortriptyline, sustained-release bupropion and placebo for smoking cessation: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Influences of mood, depression history, and treatment modality on outcomes in smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Belief about drug assignment and abstinence in treatment of cigarette smoking using nortriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Psychological intervention and antidepressant treatment in smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Extended nortriptyline and psychological treatment for cigarette smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Therapeutic drug monitoring of nortriptyline in smoking cessation: a multistudy analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Physical activity as a strategy for maintaining tobacco abstinence: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Effects of sustained-release bupropion among persons interested in reducing but not quitting smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Effects of biochemically confirmed smoking cessation on white blood cell count

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

The effect of bupropion sustained-release on cigarette craving after smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

A preliminary study of bupropion sustained-release for smoking cessation in patients with chronic posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Efficacy of bupropion in the indigenous Maori population in New Zealand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Late-term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Adherence to treatment for tobacco dependence: association with smoking abstinence and predictors of adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Selegiline transdermal system (STS) as an aid for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Incremental efficacy of adding bupropion to the nicotine patch for smoking cessation in smokers with a recent history of alcohol dependence: results from a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Effects of bupropion on simulated demand for cigarettes and the subjective effects of smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Onset of major depression during treatment for nicotine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Nicotine patch and paroxetine for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Major depression among adolescent smokers undergoing treatment for nicotine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Randomized clinical trial of the efficacy of bupropion combined with nicotine patch in the treatment of adolescent smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Markers in the 15q24 nicotinic receptor subunit gene cluster (CHRNA5-A3-B4) predict severity of nicotine addiction and response to smoking cessation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Failure to improve cigarette smoking abstinence with transdermal selegiline + cognitive behavior therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Subjective sleep disturbance during a smoking cessation program: associations with relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Psychological mediators of bupropion sustained-release treatment for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

A randomized controlled clinical trial of bupropion SR and individual smoking cessation counseling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Bupropion assists with tobacco cessation in adolescents but relapse is high

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Randomized, double-blind, placebo-controlled trial of 2 dosages of sustained-release bupropion for adolescent smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Effectiveness of bupropion as an aid to stopping smoking before elective surgery: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Influence of fluoxetine on positive and negative affect in a clinic-based smoking cessation trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Elevated positive mood: a mixed blessing for abstinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Efficacy of bupropion alone and in combination with nicotine gum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Using mediational models to explore the nature of tobacco motivation and tobacco treatment effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Effects of smoking intensity and cessation on inflammatory markers in a large cohort of active smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Smoker characteristics and smoking-cessation milestones

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

The effect of five smoking cessation pharmacotherapies on smoking cessation milestones

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Smoking cessation and quality of life: changes in life satisfaction over 3 years following a quit attempt

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Tobacco withdrawal components and their relations with cessation success

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

A randomized trial of nortriptyline for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

A randomized controlled trial of a smoking cessation intervention conducted among prisoners

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Bupropion for smokers hospitalized with acute cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Adapting smoking cessation treatment according to initial response to precessation nicotine patch

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Effectiveness of pharmacotherapy and behavioral interventions for smoking cessation in actual clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Double-blind placebo-controlled trial of fluoxetine in smoking cessation treatment including nicotine patch and cognitive-behavioral group therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Predictors of smoking cessation among cancer patients enrolled in a smoking cessation program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Action to stop smoking in suspected tuberculosis (ASSIST) in Pakistan: a cluster randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

An intervention to stop smoking among patients suspected of TB--evaluation of an integrated approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

The "bupropion for smoking cessation" trial from a family practice perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Bupropion for smoking cessation: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Sustained-release bupropion for hospital-based smoking cessation: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Comparative effectiveness of 5 smoking cessation pharmacotherapies in primary care clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

S-adenosyl-L-methionine (SAMe) for smoking abstinence: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Randomized trial of nicotine replacement therapy (NRT), bupropion and NRT plus bupropion for smoking cessation: effectiveness in clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Bupropion SR and smoking cessation in actual practice: methods for recruitment, screening, and exclusion for a field trial in a managed-care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Bupropion SR and counseling for smoking cessation in actual practice: predictors of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Joint effect of dopaminergic genes on likelihood of smoking following treatment with bupropion SR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Heterogeneity in 12-month outcome among female and male smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Effectiveness of bupropion sustained release for smoking cessation in a health care setting: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

The cost-effectiveness of antidepressants for smoking cessation in chronic obstructive pulmonary disease (COPD) patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Differences in smoking expectancies in smokers with and without a history of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Changes in smoking expectancies in abstinent, reducing, and non-abstinent participants during a pharmacological trial for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Smoking cessation in primary care - a randomized controlled trial of bupropione, nicotine replacements, CBT and a minimal intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Smoking cessation in severe mental illness: what works?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Lazabemide, a selective, reversible monoamine oxidase B inhibitor, as an aid to smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

A selective reversible monoamine oxidase B inhibitor in smoking cessation: effects on its own and in association with transdermal nicotine patch

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Preliminary effects of bupropion and the promoter region (HTTLPR) serotonin transporter (SLC6A4) polymorphism on smoking behavior in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Tryptophan and high-carbohydrate diets as adjuncts to smoking cessation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

High effectiveness of short treatment with bupropion for smoking cessation in general care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

The efficacy of the combination of sertraline with buspirone for smoking cessation. A randomized clinical trial in nondepressed smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Effectiveness of bupropion for smoking cessation during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Bupropion for the treatment of nicotine dependence in spit tobacco users: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Bupropion SR for the treatment of smokeless tobacco use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Measuring nicotine dependence among smokeless tobacco users

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Doxepin as an adjunct to smoking cessation: a double-blind pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Effects of doxepin on withdrawal symptoms in smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

A double-blind placebo-controlled cross over trial of bupropion in smoking reduction in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Does acceptance and relationship focused behavior therapy contribute to bupropion outcomes? A randomized controlled trial of functional analytic psychotherapy and acceptance and commitment therapy for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Naturalistic, self-assignment comparative trial of bupropion SR, a nicotine patch, or both for smoking cessation treatment in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Assessment of nicotine dependence among adolescent and young adult smokers: a comparison of measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Extended treatment of older cigarette smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Effects of selegiline (L-deprenyl) during smoking and short-term abstinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

The impact of chronic bupropion on plasma cotinine and on the subjective effects of ad lib smoking: a randomized controlled trial in unmotivated smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Bupropion-SR for smoking cessation in early recovery from alcohol dependence: a placebo-controlled, double-blind pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Efficacy of confrontational counselling for smoking cessation in smokers with previously undiagnosed mild to moderate airflow limitation: study protocol of a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Efficacy of confronting smokers with airflow limitation for smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Preliminary study of buprenorphine and bupropion for opioid-dependent smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Nicotine reduction and bupropion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Bupropion may support psychosocial treatment of nicotine-dependent adolescents: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Outcomes of bupropion therapy for smoking cessation during routine clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Effects of fluoxetine on weight gain and food intake in smokers who reduce nicotine intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Comparing the tolerability and effectiveness of two treatment regimens in a smoking clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

The effect of bupropion on nicotine craving and withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Triple-combination pharmacotherapy for medically ill smokers: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Intention to quit moderates the effect of bupropion on smoking urge

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Comparison of expired carbon monoxide and plasma cotinine as markers of cigarette abstinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Risk factors for treatment failure in smokers: relationship to alcohol use and to lifetime history of an alcohol use disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Comparing gain- and loss-framed messages for smoking cessation with sustained-release bupropion: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Message framing for smoking cessation: the interaction of risk perceptions and gender

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

A preliminary study of sustained-release bupropion for smoking cessation in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Effects of sustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Smoking history and motivation to quit in smokers with schizophrenia in a smoking cessation program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

A randomized, open-label pilot comparison of gabapentin and bupropion SR for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

A randomized trial of short psychotherapy versus sustained-release bupropion for smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Bupropion exposures: clinical manifestations and medical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Serious adverse reactions of bupropion for smoking cessation: analysis of the French Pharmacovigilance Database from 2001 to 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

The cost utility of bupropion in smoking cessation health programs: simulation model results for Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Experimenter-defined quit dates for smoking cessation: adherence improves outcomes for women but not for men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Evaluation of the safety of bupropion (Zyban) for smoking cessation from experience gained in general practice use in England in 2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Nicotine receptor partial agonists for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Pharmacological interventions for smoking cessation: an overview and network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

The influence of depressive symptoms on smoking cessation among African Americans in a randomized trial of bupropion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Bupropion for smoking cessation : predictors of successful outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Interventions for smokeless tobacco use cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Antidepressants and smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Effects of gender on relapse prevention in smokers treated with bupropion SR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Double blind trial of repeated treatment with transdermal nicotine for relapsed smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Bupropion in breast milk: an exposure assessment for potential treatment to prevent post-partum tobacco use

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Relapse prevention interventions for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Statistical analysis of randomized trials in tobacco treatment: longitudinal designs with dichotomous outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Bupropion as an aid to smoking cessation: a review of real-life effectiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Bupropion and the risk of sudden death: a self-controlled case-series analysis using The Health Improvement Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Nortriptyline for smoking cessation: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Depression during tobacco abstinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Smoking and suicide: a brief overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Bupropion for pharmacologic relapse prevention to smoking: predictors of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Effect of nonnicotine pharmacotherapy on smoking behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Inhibition of CYP2D6 activity by bupropion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Mediating mechanisms for the impact of bupropion in smoking cessation treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Pharmacogenetic investigation of smoking cessation treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Effect of bupropion on depression symptoms in a smoking cessation clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Treatment of nicotine dependence with bupropion SR: review of its efficacy, safety and pharmacological profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Non-nicotine pharmacotherapies for smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Suicidal behavior and depression in smoking cessation treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Use of varenicline versus bupropion and risk of psychiatric adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Toward personalized therapy for smoking cessation: a randomized placebo-controlled trial of bupropion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Gender, race, and education differences in abstinence rates among participants in two randomized smoking cessation trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Are there gender differences in smoking cessation, with and without bupropion? Pooled- and meta-analyses of clinical trials of Bupropion SR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Targeting smokers at increased risk for relapse: treating women and those with a history of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Nicotine replacement therapy for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Pharmacogenomics of fluorouracil, irinotecan, and oxaliplatin in hepatic metastases of colorectal cancer: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Smoking cessation treatment and risk of depression, suicide, and self harm in the Clinical Practice Research Datalink: prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Depressive symptoms and smoking cessation after hospitalization for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Recycling with nicotine patches in smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Zyban-- is there a cause for concern?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Molecular genetics of successful smoking cessation: convergent genome-wide association study results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Smoking cessation interventions for smokers with current or past depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Should nortriptyline be used as a first-line aid to help smokers quit? Results from a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

How does bupropion work as a smoking cessation aid?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Smoking cessation guidelines for health professionals: an update. Health Education Authority

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Bupropion SR for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Pragmatic, observational study of bupropion treatment for smoking cessation in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Nicotine and bupropion share a similar discriminative stimulus effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Anxiolytics for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Antidepressants for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Antidepressants for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Antidepressants for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

A Double-blind, Placebo-Controlled, Randomized Trial of Bupropion for Smoking Cessation in Primary Care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Tolerability and safety of sustained-release bupropion in the management of smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Clinical efficacy of bupropion in the management of smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Use of sustained-release bupropion in specific patient populations for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Bupropion for Smoking Cessation in Patients Hospitalized With Acute Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

Statistical aspects of the analysis of data from retrospective studies of disease

21 January 2018

1 reference

12 December 2020

A prospective safety surveillance study for bupropion sustained-release in the treatment of depression.

1 reference

12 December 2020

No evidence for a major role of polymorphisms during bupropion treatment

1 reference

12 December 2020

Nicotine reduction: effectiveness of bupropion

1 reference

12 December 2020

Cost-effectiveness of bupropion, nortriptyline, and psychological intervention in smoking cessation

1 reference

12 December 2020

Influences of gender and weight gain on short-term relapse to smoking in a cessation trial

1 reference

12 December 2020

Controlled Trial for Smoking Cessation in a Navy Shipboard Population Using Nicotine Patch, Sustained-Release Buproprion, or Both

1 reference

12 December 2020

Meta-analysis of suicidality in placebo-controlled clinical trials of adults taking bupropion

1 reference

12 December 2020

Nicotine-like discriminative stimulus effects of bupropion in rats

1 reference

12 December 2020

Bupropion for smoking cessation in patients with acute coronary syndrome

1 reference

12 December 2020

A comparison of sustained-release bupropion and placebo for smoking cessation

1 reference

12 December 2020

General practice counseling for patients with chronic obstructive pulmonary disease to quit smoking: impact after 1 year of two complex interventions

1 reference

12 December 2020

Cost-effectiveness of different combinations of bupropion SR dose and behavioral treatment for smoking cessation: a societal perspective.

1 reference

12 December 2020

Mood, major depression, and fluoxetine response in cigarette smokers

1 reference

12 December 2020

Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up

1 reference

12 December 2020

A Pilot Randomised, Open, Uncontrolled, Clinical Study of Two Dosages of St John’s Wort (Hypericum perforatum) Herb Extract (LI-160) as an Aid to Motivational/Behavioural Support in Smoking Cessation

1 reference

12 December 2020

Interaction of Personality and Treatment Conditions Associated with Success in a Smoking Control Program

1 reference

12 December 2020

A comparison of sustained-release bupropion and placebo for smokeless tobacco cessation.

1 reference

12 December 2020

Do serotonin uptake inhibitors decrease smoking? Observations in a group of heavy drinkers

1 reference

12 December 2020

Efficacy of sequential use of fluoxetine for smoking cessation in elevated depressive symptom smokers

1 reference

12 December 2020

Lack of effect of D2 dopamine receptor TaqI A polymorphism on smoking cessation

1 reference

12 December 2020

Buspirone effect on tobacco withdrawal symptoms: a pilot study

1 reference

12 December 2020

Sustained-release bupropion for smoking cessation in a Chinese sample: a double-blind, placebo-controlled, randomized trial

1 reference

12 December 2020

An employer-based cost-benefit analysis of a novel pharmacotherapy agent for smoking cessation

1 reference

12 December 2020

Stopping smoking: a prospective, randomized, double-blind study comparing nortriptyline to placebo

1 reference

12 December 2020

A multi‐level analysis of non‐significant counseling effects in a randomized smoking cessation trial

1 reference

12 December 2020

Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR

1 reference

12 December 2020

Bupropion and cognitive behavioral therapy for weight-concerned women smokers

1 reference

12 December 2020

Buspirone reduces smoking

1 reference

12 December 2020

Predictors of relapse in a bupropion trial for smoking cessation in recently-abstinent alcoholics: preliminary results using an aggregate genetic risk score

1 reference

12 December 2020

Assessment of the effectiveness of sustained release Bupropion and intensive physician advice in smoking cessation

1 reference

12 December 2020

A bupropion smoking cessation clinical trial for cancer patients

1 reference

12 December 2020

Bupropion SR vs placebo for smoking cessation in health care professionals

1 reference

12 December 2020

Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials

1 reference

12 December 2020

Two-year follow-up of a smoking cessation trial in patients with schizophrenia: increased rates of smoking cessation and reduction

1 reference

12 December 2020

Bupropion and cognitive-behavioral therapy for smoking cessation in women

1 reference

12 December 2020

A randomized, placebo-controlled clinical trial of bupropion for the prevention of smoking in children and adolescents with attention-deficit/hyperactivity disorder.

1 reference

12 December 2020

A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies

1 reference

12 December 2020

Double-blind fluoxetine in depressed alcoholic smokers

1 reference

12 December 2020

Predictors of 12-month outcome in smokers who received bupropion sustained-release for smoking cessation

1 reference

12 December 2020

Fluoxetine, smoking, and history of major depression: A randomized controlled trial

1 reference

12 December 2020

Weight suppression and weight rebound in ex-smokers treated with fluoxetine

2 references

12 December 2020

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

7 January 2021

A randomized trial of smoking cessation. Medication versus motivation.

1 reference

12 December 2020

Smokers' response to combination bupropion, nicotine patch, and counseling treatment by race/ethnicity.

1 reference

12 December 2020

A randomized clinical trial of St. John's wort for smoking cessation

1 reference

12 December 2020

A proof of concept randomised placebo controlled factorial trial to examine the efficacy of St John's wort for smoking cessation and chromium to prevent weight gain on smoking cessation

1 reference

12 December 2020

Side effects of antidepressants: an overview.

1 reference

12 December 2020

A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia

1 reference

12 December 2020

Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention

1 reference

12 December 2020

Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism

1 reference

12 December 2020

Antidepressant pharmacotherapy helps some cigarette smokers more than others

1 reference

12 December 2020

Depressive mood, suicide ideation and anxiety in smokers who do and smokers who do not manage to stop smoking after a target quit day.

1 reference

12 December 2020

A smoking ban in public places increases the efficacy of bupropion and counseling on cessation outcomes at 1 year.

1 reference

12 December 2020

Impact of prior nicotine replacement therapy on smoking cessation efficacy

1 reference

12 December 2020

Bupropion SR for relapse prevention: a "slips-allowed" analysis.

1 reference

12 December 2020

Genetic variants in the serotonin transporter influence the efficacy of bupropion and nortriptyline in smoking cessation

1 reference

12 December 2020

The dynamics of the urge-to-smoke following smoking cessation via pharmacotherapy.

1 reference

12 December 2020

Using extended cognitive behavioral treatment and medication to treat dependent smokers

1 reference

12 December 2020

Effect of treatment for nicotine dependence in patients with COPD

1 reference

12 December 2020

A randomized, controlled trial of bupropion sustained-release for preventing tobacco relapse in recovering alcoholics

1 reference

12 December 2020

A Phase II study of St. John's Wort for smoking cessation

1 reference

12 December 2020

Bupropion SR and contingency management for adolescent smoking cessation

1 reference

12 December 2020

Bupropion: pharmacological and clinical profile in smoking cessation.

1 reference

12 December 2020

Bupropion sustained release and smoking cessation.

1 reference

12 December 2020

Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine

1 reference

12 December 2020

Influence of antidepressant pharmacotherapy on behavioral treatment adherence and smoking cessation outcome in a combined treatment involving fluoxetine

2 references

12 December 2020

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

7 January 2021

Extended treatment with bupropion SR for cigarette smoking cessation

1 reference

12 December 2020

Efficacies of dexfenfluramine and fluoxetine in preventing weight gain after smoking cessation

1 reference

12 December 2020

Fluoxetine versus placebo to decrease the smoking of depressed alcoholic patients

1 reference

12 December 2020

Racial differences in smoking abstinence rates in a multicenter, randomized, open-label trial in the United States

1 reference

12 December 2020

A double-blind, placebo-controlled, randomized clinical trial of oral selegiline hydrochloride for smoking cessation in nicotine-dependent cigarette smokers

1 reference

12 December 2020

Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia.

1 reference

12 December 2020

Multicenter trial of fluoxetine as an adjunct to behavioral smoking cessation treatment

1 reference

12 December 2020

Cost-benefit analysis of sustained-release bupropion, nicotine patch, or both for smoking cessation

1 reference

12 December 2020

Development of major depressive disorder during smoking-cessation treatment

1 reference

12 December 2020

Cost-effectiveness of bupropion, nortriptyline, and psychological intervention in smoking cessation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

7 January 2021

Oxygen therapy in the breathless patient

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000031.PUB4

7 January 2021

10.1002/14651858.CD000031.PUB4

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

404875

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24402784%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

404875

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24402784%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

PubMed publication ID

24402784

2 references

Consolidated OpenCitations Corpus – April 2017

404875

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24402784%20AND%20SRC:MED&resulttype=core&format=json